Tissue ablation systems and methods of use

Information

  • Patent Grant
  • 8900223
  • Patent Number
    8,900,223
  • Date Filed
    Monday, November 8, 2010
    13 years ago
  • Date Issued
    Tuesday, December 2, 2014
    9 years ago
Abstract
This invention relates to medical instruments and systems for applying energy to tissue. Variations of the systems and methods described herein include ablating, sealing, and extracting tissue with high pressure flows of fluids that in part utilizes a vapor-to-liquid phase change of flow media to apply thermal energy to the tissue.
Description
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a non-provisional of U.S. Patent Application No. 61/259,097 filed on Nov. 6, 2009, the content of which is incorporated herein by reference in its entirety.


The systems and methods described herein are also related to: U.S. Patent Provisional Application No. 61/126,647 filed May 6, 2008 entitled MEDICAL SYSTEM AND METHOD OF USE; Application No. 61/126,651 filed May 6, 2008 entitled MEDICAL SYSTEM AND METHOD OF USE; U.S. Application No. 61/126,612 filed May 6, 2008 entitled MEDICAL SYSTEM AND METHOD OF USE; Application No. 61/126,636 filed May 6, 2008 entitled MEDICAL SYSTEM AND METHOD OF USE; Application No. 61/130,345 filed May 31, 2008 entitled MEDICAL SYSTEM AND METHOD OF USE; Application No. 61/191,459 filed Sep. 9, 2008 entitled MEDICAL SYSTEM AND METHOD OF USE; Application No. 61/066,396 filed Feb. 20, 2008 entitled TISSUE ABLATION SYSTEM AND METHOD OF USE; Application No. 61/123,416 filed Apr. 8, 2008 entitled MEDICAL SYSTEM AND METHOD OF USE; Application No. 61/068,049 filed Mar. 4, 2008 entitled MEDICAL SYSTEM AND METHOD OF USE; Application No. 61/123,384 filed Apr. 8, 2008 entitled MEDICAL SYSTEM AND METHOD OF USE; Application No. 61/068,130 filed Mar. 4, 2008 entitled MEDICAL SYSTEM AND METHOD OF USE; Application No. 61/123,417 filed Apr. 8, 2008 entitled MEDICAL SYSTEM AND METHOD OF USE; Application No. 61/123,412 filed Apr. 8, 2008 entitled MEDICAL SYSTEM AND METHOD OF USE; Application No. 61/126,830 filed May 7, 2008 entitled MEDICAL SYSTEM AND METHOD OF USE; and Application No. 61/126,620 filed May 6, 2008 entitled MEDICAL SYSTEM AND METHOD OF USE.


The systems and methods described herein are also related to U.S. patent application Ser. No. 10/681,625 filed Oct. 7, 2003 entitled MEDICAL INSTRUMENTS AND TECHNIQUES FOR THERMALLY-MEDIATED THERAPIES; application Ser. No. 11/158,930 filed Jun. 22, 2005 entitled MEDICAL INSTRUMENTS AND TECHNIQUES FOR TREATING PULMONARY DISORDERS; application Ser. No. 11/244,329 filed Oct. 5, 2005 entitled MEDICAL INSTRUMENTS AND METHODS OF USE and application Ser. No. 11/329,381 filed Jan. 10, 2006 entitled MEDICAL INSTRUMENT AND METHOD OF USE.


All of the applications discussed throughout this disclosure are incorporated herein by this reference and made a part of this specification, together with the specifications of all other commonly-invented applications cited in the above applications.


FIELD OF THE INVENTION

This invention relates to medical instruments and systems for applying energy to tissue. Variations of the systems and methods described herein include ablating, sealing, and extracting tissue with high pressure flows of fluids that in part utilizes a vapor-to-liquid phase change of flow media to apply thermal energy to the tissue.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is a tissue ablation system corresponding to the invention that utilizes high pressure flows of a flow media delivered into tissue from the working end of a probe to allow the controlled ablation of targeted tissue, and aspiration of ablated tissue.



FIG. 2 is a handle component of the ablation system of FIG. 1.



FIG. 3 is a schematic a schematic representation of an inductive heater component of the ablation system of FIG. 1 that is configured to convert a flow of liquid flow media into a flow of vapor and fluid droplets for jetting from the working end of the probe.



FIG. 4A is a cut-away view of the extension member of the ablation probe of FIG. 1.



FIG. 4B is a perspective view of the working end of the ablation probe of FIG. 1.



FIG. 5 is a schematic representation of a spinal disc showing the ablation probe and working end of FIG. 4B following insertion of the working end into the nucleus, and its movement to ablate and extract the gelatinous nucleus without ablating the annulus.



FIG. 6A is a perspective view of an alternative working end of an ablation probe similar to that of FIGS. 4A and 4B with flow outlets in an angled tissue-contacting surface and aspiration port, the flow outlets having converging axes for jetting flow media to ablate tissue.



FIG. 6B is a sectional view of the working end of FIG. 6A taken along line 6B-6B of FIG. 6A showing the axes of the flow outlets coupled to first and second sources of different flow media.



FIG. 7 is a perspective view of an alternative working end of an ablation probe similar to that of FIGS. 6A-6B with a laterally-facing tissue-ablating surface, with the aspiration port and flow media outlets having outwardly directed axes for jetting flow media to ablate tissue.



FIG. 8 is a perspective view of an alternative working end similar to that of FIG. 7 with a sharp distal comprising an RF electrode for abating tissue.



FIG. 9 is a perspective view of another working end similar to that of FIGS. 7 and 8 with extendable-retractable sharp distal for penetrating tissue.



FIG. 10 is a perspective view of another working end similar to that of FIGS. 4A and 7 with concentric first and second flow outlets supported in a centrally position in an aspiration port together with a loop member for scraping tissue.



FIG. 11 is a perspective view of another working end similar to that of FIG. 10 with concentric first and second flow outlets with a surrounding aspiration port together with a plurality of brush elements for brushing tissue.



FIG. 12 is a perspective view of another working end with an elongated aspiration port in a knife-like edge and surrounding flow media outlets.



FIG. 13A is a representational view of another working end that is moveable axially and rotationally with multiple outlets for jetting flow media to cut, ablate disintegrate and remove tissue, with the figure showing rotational movement and cutting paths.



FIG. 13B is another view of the working end of FIG. 13A showing axial movement and cutting paths.





DETAILED DESCRIPTION


FIGS. 1 and 2 depict an embodiment corresponding to the invention that provides an ablation system 100 that utilizes controlled high pressure flows of a flow media to ablate, disintegrate, seal and optionally remove tissue from a patient's body. FIG. 1 shows an ablation probe 105 that is configured with a pistol-grip handle member 106 for gripping with a human hand. The handle member 106 alternatively can be any in-line handle or other type of handle, or any proximal handle end adapted for connection to a surgical robot. In one embodiment shown in FIGS. 1 and 2, the handle comprises first and second detachable components, 108A and 108B. Handle component 108A is coupled to an elongated extension member 110 extending along a longitudinal axis 115 to a distal working end 120. The axial extension member 110 can have a suitable length and diameter for a particular ablation procedure, and can range from 1 mm to 10 mm in cross section and can be rigid, semi-rigid, deflectable, hinged or deformable. The extension member 110 also can be configured for with a channel for accommodating a rigid or flexible endoscope or a disposable optic fiber to provide viewing means for navigating the working end in the interior of a patient's body. As will be described below, the system is configured to deliver at least one flow of a flow media, such as water vapor, atomized water droplets or a jet of water in a pulsed or continuous mode, any of which can be configured to ablate tissue. The use of water vapor and fluid jets to ablate tissue has been described in the following co-pending U.S. patent applications: U.S. patent application Ser. No. 10/681,625 filed Oct. 7, 2003 titled “Medical Instruments and Techniques for Thermally-Mediated Therapies”; Ser. No. 11/158,930 filed Jun. 22, 2005 titled “Medical Instruments and Techniques for Treating Pulmonary Disorders”; Ser. No. 11/244,329 filed Oct. 5, 2005 titled “Medical Instruments and Methods of Use” and Ser. No. 11/329,381 filed Jan. 10, 2006 titled “Medical Instrument and Method of Use”. All of the above applications are incorporated herein by this reference and made a part of this specification, together with the specifications of all other commonly-invented applications cited in the above applications.


The generation and delivery of a collapsible, high energy vapor for various therapeutic procedures is further disclosed in systems with remote vapor generation systems or sources in co-pending applications 60/929,632, 61/066,396, 61/068,049, or with vapor generator in a handle or working end, or combination thereof, as described in applications 61/068,130, 61/123,384, 61/123,412, 61/126,651, 61/126,612, 61/126,636, 61/126,620 all of which are incorporated herein by reference in their entirely.



FIGS. 1 and 2 illustrate an embodiment of tissue ablation system 100 in which detachable handle component 108B carries a heat applicator system for converting a fluid flow to a vapor flow which comprises an inductive heater assembly 124 operatively coupled to an electrical source such as an RF generator 125. The inductive heater 124 is adapted for converting a pressurized flow of a liquid, such as water or saline, into a flow of water vapor, or a pulsed flow of water vapor, atomized water droplets and/or a flow of water. The inductive heater 124 can be as described in U.S. Provisional patent application Ser. No. 12/389,808 incorporated by reference herein. In FIG. 2, it can be seen that a pressurized flow media source 140 contains the fluid or flow media 150 such as water or saline. The source 140 delivers the flow media through flexible conduit 142 and cooperating fittings 144A and 144B to handle component 108B and to inductive heater 124 (FIGS. 2 and 3). The pressurized fluid source 140 and computer controller 155 is adapted to deliver the flow media 150 at a controlled flow rate and pressure through a flow channel 160 into the inductive heater 124 and through flow channel 162 out of the inductive heater into at least one cooperating flow channel 166 in extension member 110 that communicates with at least one flow outlet 170 in the working end 120 (FIGS. 4A-4B). The flow rate of media into the inductive heater 124 can range from 0.01 ml/min to 20 ml/min and provides at pressures of between 10 psi and 10,000 psi.


As can be seen in FIGS. 2 and 3, the flow of liquid flow media 150 is directed through the inductive heater 124 that is housed in handle component 108B. The handle 106 can comprise a molded shell of a plastic and can provide an air gap or insulation 172 around the inductive heater 124. In one embodiment (FIG. 3), the inductive heater 124 comprises a ceramic cylinder 174 about 1.0″ to 1.5″ in length and 0.25″ in diameter with a 0.10″ bore 176 therein. The bore 176 contains an inductively heatable structure with a plurality of axial microchannels for receiving fluid flows which in one embodiment can be provided by a tightly-packed assembly of small diameter microtubes 177. The microtubes 177 can be any suitable material, for example any stainless steel (e.g., 316 SS) that can be instantly heated by induction. In one embodiment, the stainless steel microtubes 177 are 0.016″ thin wall tubes. A winding 180 of one to ten layers having with the winding having an axial length of 1.0″ is provided about the cylinder 172 for inductive heating of microtubes 177 using very high frequency current from electrical source 125. In one embodiment the winding 180 can be 26 Ga. Copper wire with a Teflon coating. It has been found that delivering at least 50 W, 100 W, 200 W, 300 W, or 400 W with suitable flow rates of water through the channels in and around the microtubes 177 can produce very high quality water vapor, for example 95% vapor or higher. An insulation layer 172 is provided about an exterior of the inductive heater, as depicted in phantom view in FIG. 3. The insulation can comprise an air or partial vacuum gap, an aerogel, insulating glass or ceramic microspheres or another insulator material. In general, the inductive heater 124 and controller 155 can be configured to produce a high quality vapor with precise parameters in terms of vapor quality, exit vapor pressure from the working end 120 and exit vapor temperature, together with maintaining the parameters within a tight range over a treatment interval. All these parameters can be controlled with a high level of precision to achieve controlled dosimetry, no matter whether a particular tissue ablation treatment calls for (i) very low pressures in tissue (e.g., 0.1 to 5 psi) over a treatment interval or (ii) very high pressures (50 psi or greater) and no matter whether the treatment interval is in the 1-10 second range or 2 to 5 minute range.


In some tissue ablation procedures, it has been found that introducing and navigating the extension member 110 and working end 120 is best accomplished by gripping handle component 108A without the laterally extending handle component 108B. The physician can also maneuver the probe 105 more easily without the additional weight and bulk of handle component 108B. For this reason, an embodiment of probe 105 can provide detachable handle components 108A and 108B. FIGS. 1 and 2, it can be seen that handle component 108B is detachably coupled to handle component 108A by first and second projecting grip-tab elements 184a and 184b that are configured to project into receiving slots in handle component 108A. Push-buttons 186a and 186b in handle 108B can be depressed to release the handle components 108A and 108B from one another. Alignment pins 188 in handle component 108B cooperate with receiving bores in handle component 108A to align the handle components when being attached to on another.


Referring to FIG. 2, a tubular projecting element 190 with flow channel 165 therein extends outwardly from handle component 108B and is configured for a fluid-tight fit in a cooperating fitting (not shown) in handle component 108A. One or more o-rings can be used to provide a fluid-tight seal around element 190 or the flow channel 165 that extends to the working end 120.


In one embodiment depicted in FIGS. 1 and 2, a second pressurized source 200 of a second flow media 205 is coupled to a flow channel in conduit 142 and to a second flow channel 210 in handle component 108B that extends from fittings 144A and 144B to a second tubular projecting element 220 that extends outwardly from handle component 108B similar to projecting element 190. The second projecting element 220 and channel 210 therein are configured for a fluid-tight fit to a cooperating fitting and flow channel 222 in handle component 108A (not shown) that can extends through extension member 110 to working end 120 as shown in one embodiment in FIGS. 6A-6B. As can be seen in FIG. 2. the second flow media source 200 bypasses the inductive heater 124 and can deliver a flow of a gas or liquid to the working end 120 for one or more purposes, with the a continuous or pulsed flow optionally controlled by controller 155. In an embodiment, the second flow media can comprise a pharmacologic agent that is delivered to tissue from a dedicated outlet in the working end or the agent can be mixed with the heated flow media in the extension member 110 or working end 120. In another embodiment, the second flow media 205 can comprise a high pressure fluid flow that is adapted for ejection or jetting from a dedicated outlet in the working end to disintegrate tissue, or the flow can be jetted out of at least one outlet 170 (FIG. 4B) that delivers the first flow media 150. In another embodiment, the second flow media 205 can comprise a flow of gas that is adapted mixing with the heated flow media to lower its mass average temperature. In another embodiment, the second flow media can comprise a cooling gas or liquid for cooling targeted tissue or adjacent tissue after or during after an ablative treatment.


Referring to FIGS. 1, 4A and 4B, the system 100 further includes a negative pressure source 240 also controlled by controller 155 for optionally applying aspiration forces through an aspiration channel 244 in extension member 110 that extends to at least one open aspiration port 245 in the working end 120 (FIG. 4B). The negative pressure source 240 can be connected to a valved port 248 in handle component 108A that communicates with the aspiration channel 244 (FIG. 1).


Referring to FIGS. 4A-4B, it can be seen that an embodiment of working end 120 comprises a plurality of flow outlets 170 spaced apart and positioned around an open aspiration port 245. In one embodiment, a plurality of flow channels 166 in extension member 110 carry the flow media 150 to the working end 120 but a single channel can branch to the outlets or an annular channel can communicate with outlets 170. The aspiration port 245 and aspiration channel 244 are as large as possible in relation to the cross-section of extension member 110, to maximize aspiration forces at the port 245. The extension member 110 can have a cross section ranging from about 1 mm to 10 mm for various tissue ablation applications. The aspiration port 245 can be singular or plural, and can be round, oval, elongated or comprise one or more narrow slits along a blade-like edge. In The working end has a surface 250 surrounding the aspiration port 245 that is configured for contacting tissue or moving over tissue targeted for ablation. The flow outlets 170 can be disposed in surface 250 or in a recessed surface 252 that extends around port 245 that is angled or beveled relative to surface 250. The plane P of surface 250 and port 245 is 90° relative to axis 115 in the embodiment of FIGS. 4A-4B, but the angle of the plane of port 245 can be angled relative to axis 115 or parallel and offset from axis 115 as will be described below (see FIGS. 6A-6B). The flow outlets can range in number from 2 to 40 or more, and in the embodiment of FIGS. 4A-4B comprises four outlets 170. The axis 260 of media flows jetted from the flow outlets can be aligned with axis 115 or any other angle that is angled inward toward axis 115 or retrograde relative to axis 115. The flow outlets 170 range in diameter from about 0.0005 inches to 0.020 inches.


In use, the inductive heater 124 is configured to apply energy to a flow of flow media 150 to convert the media to vapor. The flow media may be provided at pressures ranging from 1 psi to 1000 psi and flow rates described above, in either a continuous flow or pulsed flows. In a method corresponding to the invention, the media flows from outlets 170 can have a predetermined vapor quality. For example when the flow media 150 is water, the vapor media may range from about 50% to 99% water vapor with the non-vapor portion comprising water droplets. By controlling the inflow pressure and flow rate from source 140, the applied energy from heater 124, the number and cross-section of outlets 170, it is possible to control the water vapor component and the water droplet component of flows jetted or ejected from outlets 170 to optimize the jetted flow media for a ablation of a particular tissue. The vapor component of the jetted media condenses to apply thermal energy to targeted tissue which will cause thermal damage, weakening and denaturation of proteins and tissue constituents. At the same time the water droplet component can apply sufficient mechanical forces to disintegrate and volumetrically remove tissue at the flow media-tissue interface. Thus, in one aspect of the invention, the quality of the vapor, i.e., the combination of jetted vapor with jetted water droplets, is configured for cutting the thermally weakened tissue while the aspiration forces through port 245 extracts and removes the tissue. By controlling the vapor quality and jetting pressure or velocity as described above, the thermal and mechanical energy applied to tissue can be modulated to discriminate between or non-ablation or tissues within a targeted tissue volume. In one method, an ablation system can be designed for treating spinal discs to ablate and extract a disc nucleus. The vapor quality and jetting velocity is controlled to discriminate between ablation of a disc nucleus and annulus. In another method, a small diameter probe can select a particular vapor quality and jetting velocity for cutting soft brain tissue without damaging microvasculature. Various neurosurgeries require cutting brain tissue without damage to tougher, elastic vasculature. In another method, a probe can use a selected vapor quality and jetting velocity for cutting any soft tissue without damaging elastic vasculature.


Referring to FIG. 5, one embodiment of system 100 is shown for use in ablating tissue in a nucleus 300 of disc 302. In various procedures to replace a disc nucleus with and artificial nucleus, or in disc decompression procedure or in a fusion procedure, it is desirable to use a tool to ablate and remove a nucleus 300 without damaging the disc annulus 310. Since the procedure is best accomplished with a small diameter probe without viewing means for viewing the targeted tissue, a probe with tissue-discrimination capabilities is needed. In the systems described above, a working end 120 as depicted in FIGS. 4B and 5 can be provided with operating parameters configured that ablate and remove the soft nucleus tissue 300 to thereby create space 308 wherein the operating parameters are not capable of ablating or cutting the disc annulus 310. In other words, the thermal energy provided by the flow and mechanical energy applied by the velocity of water or water droplets imparts energy to disintegrate soft nucleus tissue but does not impart enough energy to disintegrate tougher annulus tissue. In an embodiment configured for disc nucleus ablation, the probe extension member 110 can have a straight axis, slightly curved axis, or articulating working end and can be moved axially, angled and rotated to ablate and extract the disc nucleus as indicated schematically in FIG. 5. Minimally invasive percutaneous access to the disc is known in the art, and can use an access cannula (not shown). As will be described below, the working end 120 can have the outlets 107 and an aspiration port 245 with an distal-facing orientation, an angled orientation or a side-facing orientation.



FIGS. 6A and 6B are perspective and cross-section views of an alternative working end 120 of an ablation probe similar to that FIGS. 1, 4A and 4B, showing an central aspiration channel 244 and port 245 surrounded by an angled distal surface 250 that is angled relative to axis 115. The plane P of surface 250 and port 245 can range from about 30° to 90° relative to axis 115 (FIG. 6B). In this embodiment, the surface 250 is angled and configured for contacting tissue or moving over tissue targeted for ablation. In one embodiment shown in FIGS. 6A-6B, the probe extension member 110 and working end 120 are configured to eject first and second flows of flow media 150 and 205 from first flow media source 140 and second flow media source 200, respectively, to impart energy to disintegrate tissue. In the embodiment of FIGS. 6A-6B, a plurality of flow outlets 170a-170d are disposed in surface in recessed surface 252 that extends around port 245. The flow outlets 170a-170d in surface 252 can have converging axes, (e.g., axes 315a and 315b) which can be at various angles relative to surface 250 and axis 115 of the probe. As can be seen in the FIG. 6B, the flow channels 166 can have a tapered or step-region 316 that reduces the channel cross-section to a small diameter nozzle portion indicated at 318. The working end 120 of FIGS. 6A-6B can be used as shown in FIG. 5, wherein the working end can translated axially and rotated to ablate tissue both distally and to the side of working end 120. The distal tip 318 of the working end can be blunt, sharp, abrasive or serrated. In one embodiment depicted in FIGS. 6A-6B, the flow media 150 from first flow media source 140 is jetted from ports 170a-170c and can comprise a water vapor 150 produced by inductive heater 124, with the vapor media configured to condense and apply thermal energy to tissue, for reasons described above, such a weakening bonds in tissue to allow the mechanical force of jetted fluid flow 205 to more easily disintegrate tissue. The second flow media 205 can be a high pressure fluid jet that is ejected from outlet 170d and is configured to disintegrate or cut tissue.



FIG. 7 is a perspective representation of an alternative working end 120 of an ablation probe that has flow media jetting features similar to that of FIGS. 6A and 6B. The working end 120 of FIG. 7 has a laterally-facing aspiration port 245 surrounded by angled surface 252 in plane P with the working end again configured with at least one flow outlet or a plurality of flow outlets 170a-170d as shown in FIG. 7. Further, the tissue-ablating surface 320 comprising the aspiration port 245 and flow outlets 170a-170d is within a motor-driven inner rotatable sleeve 325 that rotates relative to a non-rotatable outer concentric sleeve 330 that is coupled to a proximal handle. The distal end 332 of the inner sleeve 325 is shown as being blunt, but can also be a sharp penetrating tip. The inner sleeve can be rotated my any motor drive 335, such as an electric motor or air motor at speeds ranging from 10 rpm to 10,000 rpm and can be controlled by controller 155 to rotate in a continuous mode, an oscillating mode or any other continuous, pulsed or intermittent modes. In the embodiment of FIG. 7, the working end is again coupled to first and second flow media sources, 140 and 200 in communication with outlets 170a-170d for ablating tissue. The working end can have one or more flow outlets within any surface 250 or 252 of the working end in the plane P of the aspiration port 245 or inward a distance D of from 0 mm to about 5 mm from plane P.



FIG. 8 is a perspective representation of an alternative working end 120 similar to that of FIGS. 6A and 7. The working end 120 of FIG. 8 can be rotatable by a motor drive or manually moved. The working end 120 of FIG. 8 further comprises a distal tip that comprises at least one RF electrode 340 for ablating tissue. In FIG. 8, the electrode 340 is a monopolar electrode that cooperates with a ground pad or return electrode on extension member 110. The distal electrode 340 can be actuated to assist in navigating or advancing the tip through tissue in the interior of a patient's body prior to using the flow media to ablate and extract tissue. The electrode 340 is operatively connected to a medical RF generator as in known in the art (not shown). In all other respects, the working end 120 of FIG. 8 would function as described previously.



FIG. 9 is another working end 120 similar to that of FIGS. 6A, 7 and 8 that includes an extendable-retractable member 350 with sharp tip 352 for penetrating tissue in the interior of a patient's body, for example, to reach the tissue targeted for ablation with the high pressure flow media of the invention. In all other respects, the working end 120 of FIG. 8 would function as described previously.



FIG. 10 is a perspective representation of another working end 120 of an ablation probe that is similar to that of FIGS. 4A-4B. In the embodiment of FIG. 10, the extension member 110 and working end 120 is coupled to first and second flow media sources, 140 and 200 in communication concentric flow channels nested outer and inner hypotubes 360 and 362 that are supported within the central portion of aspiration channel 244. The first flow media 150 can comprise a condensable vapor media for delivering thermal energy to tissue and is jetted from annular flow channel 355a and flow outlet 370a of the assembly of hypotubes 360 and 362. That is, the flow channel 355a comprises the annular lumen between outer surface of inner hypotube 362 and the inner surface of the bore of the outer hypotube 360. The second flow media 205 can comprise a fluid jet such as water for disintegrating tissue as described above, with the second media 205 jetted flow channel 355b and outlet 370b in the distal end of inner hypotube 362. The distal end of the assembly of hypotubes 360 and 362 can be positioned inward from plane P of surface 250 a distance of 0 mm to about 5 mm. The working end of the FIG. 10 also includes an optional loop member 380 that extends across the aspiration port 245 and can be used to rotate against tissue during an ablation treatment to scrape and apply additional mechanical force against tissue to be extracted. The working end of FIG. 10 further can be motor driven as the embodiment of FIG. 7 (not shown) to thus function as a device to core tissue. The loop member 380 of FIG. 10 also can comprise an extendible member that can extend from about 0 mm to 10 mm from surface 250. It also should be appreciated that all the features of the working end 120 of FIG. 10 can be configured in an angled or side-facing tissue-ablation surface as in the embodiments of FIGS. 6A and 7.



FIG. 11 is another working end 120 similar to that of FIG. 10 that includes brush elements 390 that can number from 1 to 20 that can be a flexible or substantially rigid metal or plastic and can be used for brushing tissue and can be useful in ablation and discrimination of softer and denser tissues. The brushes 390 can also be extendable and retractable in channels 392 in the working end by operation of an actuator in a handle end of the probe.



FIG. 12 is a perspective representation of an alternative working end 120 similar to those previously described that can be used as an ablative knife edge 398 to cut and coagulate tissue, for example, for use in cutting liver tissue in a liver resection procedure. The extension member 110 and working end 120 can be coupled to only a first flow media source or both first and second flow media sources, 140 and 200, as shown in FIG. 12. The first flow media source 140 can comprise a source of a condensable vapor media for delivering thermal energy to tissue that is jetted from outlets 170 (collectively) on one side of elongate aspiration port 245. The second flow media source 200 can comprise a source of a fluid that is jetted from outlets 170′ (collectively) on the opposing side of aspiration port 245. The outlets 170 and 170′ can range in number from about 1 to 20. The width W of the knife edge 398 can range from about 0.2 mm to 5 mm. The length of the aspiration channel 245 can range from 1 mm to 10 mm and can be in curved or straight surfaces 252 about the aspiration port 245.


In another embodiment, referring to FIGS. 13A and 13B, an ablation system 400 can have an extension member 410 and working end 420 that has at least one flow outlet 170 for jetting flow media at a pressure and velocity configured to disintegrate or cut tissue. Like the working ends of FIGS. 7, 10 and 11 above, the working end 420 of FIG. 13A is rotatable at from 10 rpm to 10,000 rpm and by means of a motor drive 335 and controller 155. As can be seen in FIG. 13B, the working end 420 also is moveable axially by means of the motor drive and controller 155. Thus, the motor drive 335 and controller 155 can move the working end and flow outlets 170 in any pattern or sequence of angular, axial or helical motion to disintegrate, cut and ablate tissue.


In one aspect of the invention, the angular or axial movement of the flow outlet or outlets is controlled by controller 155 to limit the depth of tissue disintegration or cutting. It can be understood that at a selected flow pressure, fluid mass and flow velocity, the jetting of flow media can be configured to cut a selected depth until the flow pressure, velocity and mass is diminished and dispersed so as to longer disintegrate tissue. For example, in one embodiment, the jetted flow media from outlets 170 can have a flow pressure, mass and velocity that disintegrates tissue to a depth of 0.5 mm/s for a predetermine width of jetted flow media. In this embodiment, the working end 420 can have a circumference of 3.0 mm. Thus, rotating the working end of FIG. 13A and outlet at 60 rpm can provide a depth of tissue disintegration of 0.05 mm in a 360° path for each revolution adjacent the flow outlet. By higher speed rotation, the depth of tissue disintegration can be controlled to provide selected thin depths of ablation. By rotating in a helical pattern, an elongated tissue disintegration and ablation can be provided adjacent each flow outlet.


Thus, on aspect of a method of the invention is to controllably rotate a working end outlet that jets flow media so that tissue is disintegrated to a depth of less than 1.0 mm for each 360° revolution of the outlet, or less than 0.5 mm for each 360° revolution of the outlet or less than 0.1 mm for each 360° revolution of the outlet. The method further comprises using a plurality of jets of flow media about parallel axes or converging axes as in the device of FIG. 7.


Referring to FIGS. 13A and 13B, the working end 420 also includes an extendable-retractable sleeve 440 with aspiration channel 444 and aspiration port 445 therein. It can be understood that the sleeve 440 can be moved over the region of flow outlets 170 to remove disintegrated tissue and flow media. The negative pressure source 240 communicates with aspiration channel 444 as in previous embodiments. In other embodiments, the distal end 448 of sleeve 440 and aspiration port 445 can be distally-facing, angled or the rotatable extension member 410 can be within a side-facing aspiration port as in the embodiments of FIGS. 7-9 above.


In another aspect of the invention in FIGS. 13A and 13B, it can be seen that first and second flow media sources 140 and 200 are coupled to at least one flow channels 450 in extension member to deliver first and second flow media 150 and/or 205 through outlets 170. In one embodiment, flows of the first and second media 150 and 205 are jetted through a single channel 450 in successive intervals to disintegrate and seal tissue outward of outlets 170. In another embodiment, a first media 150 comprising a water vapor is flowed continuously and a second media of liquid water is pulsed from outlets 170. In another embodiment, two independent flow channels are provided in the extension member 410 that leads to independent flow outlets 170 (not shown).


In another aspect of the invention, the working end 420, flow media sources 140 and 200 and controller 155 can provide a first controlled pressure that is greater than 5 psi, 10 psi, 20 psi, 30 psi, 40 psi, 50 psi, 100 psi, 200 psi, 500 psi or 1000 psi for disintegrating or cutting tissue. The flow media can be any high quality vapor, low quality vapor, water or saline solution. In such an embodiment, the system can provide a second controlled pressure that is less than 50 psi, 40 psi, 30 psi, 20 psi, 10 psi and 5 psi. In use, the flow media at the second controlled pressure applies heat for sealing tissue about the disintegrated tissue region.


Although particular embodiments of the present invention have been described above in detail, it will be understood that this description is merely for purposes of illustration and the above description of the invention is not exhaustive. Specific features of the invention are shown in some drawings and not in others, and this is for convenience only and any feature may be combined with another in accordance with the invention. A number of variations and alternatives will be apparent to one having ordinary skills in the art. Such alternatives and variations are intended to be included within the scope of the claims. Particular features that are presented in dependent claims can be combined and fall within the scope of the invention. The invention also encompasses embodiments as if dependent claims were alternatively written in a multiple dependent claim format with reference to other independent claims.

Claims
  • 1. A method of treating tissue, the comprising: positioning a probe working end in an interface with tissue;ejecting a high pressure flow of flow media from a working end outlet, wherein the flow comprises at least in a part a condensable vapor, and wherein the flow has a selected pressure and velocity that disintegrates tissue; andcontrollably rotating the working end at a selected speed to control the depth of disintegration of tissue proximate the outlet.
  • 2. The method of claim 1 wherein the high pressure flow is jetted from a plurality of outlets at or along the working end.
  • 3. The method of claim 1 wherein the flow media is selected from the group of water vapor, atomized water droplets, water and a pharmacological agent.
  • 4. The method of claim 1 wherein the working end is rotated so that tissue is disintegrated to a depth of less than 1 mm for each 360° revolution of the outlet.
  • 5. The method of claim 1 wherein the working end is rotated so that tissue is disintegrated to a depth of less than 0.5 mm for each 360° revolution of the outlet.
  • 6. The method of claim 1 wherein the working end is rotated at a rate so that tissue is disintegrated to a depth of less than 0.1 mm for each 360° revolution of the outlet.
  • 7. The method of claim 1 wherein the working end is rotated at a rate so that tissue is disintegrated to a depth of less than 1 mm for each 360° revolution of the outlet.
  • 8. The method of claim 1 wherein the working end is rotated at a rate so that tissue is disintegrated to a depth of less than 0.5 mm for each 360° revolution of the outlet.
  • 9. The method of claim 1 wherein the working end is rotated at a rate so that tissue is disintegrated to a depth of less than 0.1 mm for each 360° revolution of the outlet.
  • 10. The method of claim 1 wherein the working; end is rotated between a rate of 10 rpm to 10,000 rpm.
  • 11. The method of claim 1 further comprising removing disintegrated tissue through an aspiration port communicating with an aspiration channel in the probe.
  • 12. The method of claim 1 wherein the condensable vapor applies heat to seal tissue.
  • 13. The method of claim 1 wherein the working end has a longitudinal axis and flow media is ejected at an angle relative to the axis.
  • 14. A method of tissue ablation, comprising: positioning a probe working end in an interface with a tissue volume containing first and second tissue types;ejecting at least one high pressure flow of flow media from the probe working end, wherein a flow comprises at least in a part a condensable vapor that applies energy capable of sealing tissue, wherein the flow has a selected pressure and velocity that applies energy that discriminates disintegration of tissue between the first and second tissue types,moving the working end axially and/or rotationally contemporaneous with ejecting flow media; andremoving disintegrated tissue through an aspiration port communicating with an aspiration channel in the probe.
  • 15. The method of claim 14 wherein at least two flow of different flow media are ejected from the working end.
  • 16. The method of claim 15 wherein different flow media are selected from the group of water vapor, atomized water droplets, water and a pharmacological agent.
  • 17. The method of claim 14 wherein the flow media is ejected from a plurality of outlets in the working end.
  • 18. The method of claim 14 wherein the flow media is ejected from at least one outlet that is recessed within, the aspiration port.
  • 19. The method of claim 14 wherein the flow media is pulsed.
  • 20. The method of claim 14 wherein a computer controller and motor controllably moves the working end.
  • 21. The method of claim 14 wherein a computer controller controls parameters of the ejection of flow media.
  • 22. The method of claim 14 further comprising imaging the flow of flow media.
US Referenced Citations (453)
Number Name Date Kind
408899 Bioch et al. Aug 1889 A
697181 Smith Apr 1902 A
1719750 Bridge et al. Sep 1927 A
3818913 Wallach Jun 1974 A
3880168 Berman Apr 1975 A
3930505 Wallach Jan 1976 A
4024866 Wallach May 1977 A
4083077 Knight et al. Apr 1978 A
4447227 Kotsanis May 1984 A
4672962 Hershenson Jun 1987 A
4682596 Bales et al. Jul 1987 A
4748979 Hershenson Jun 1988 A
4773410 Blackmer et al. Sep 1988 A
4793352 Eichenlaub Dec 1988 A
4872920 Flynn et al. Oct 1989 A
4898574 Uchiyama et al. Feb 1990 A
4915113 Holman Apr 1990 A
4950266 Sinofsky Aug 1990 A
4985027 Dressel Jan 1991 A
5006119 Acker et al. Apr 1991 A
5011566 Hoffman Apr 1991 A
5084043 Hertzmann et al. Jan 1992 A
5102410 Dressel Apr 1992 A
5112328 Taboada et al. May 1992 A
5122138 Manwaring Jun 1992 A
5158536 Sekins et al. Oct 1992 A
5162374 Mulieri et al. Nov 1992 A
5190539 Fletcher et al. Mar 1993 A
5217459 Kamerling Jun 1993 A
5217465 Steppe Jun 1993 A
5263951 Spears et al. Nov 1993 A
5277696 Hagen Jan 1994 A
5298298 Hoffman Mar 1994 A
5306274 Long Apr 1994 A
5318014 Carter Jun 1994 A
5331947 Shturman Jul 1994 A
5334190 Seiler Aug 1994 A
5344397 Heaven et al. Sep 1994 A
5348551 Spears et al. Sep 1994 A
5352512 Hoffman Oct 1994 A
5417686 Peterson et al. May 1995 A
5424620 Cheon et al. Jun 1995 A
5433708 Nichols et al. Jul 1995 A
5433739 Sluijter Jul 1995 A
5462521 Brucker et al. Oct 1995 A
5500012 Brucker et al. Mar 1996 A
5503638 Cooper et al. Apr 1996 A
5524620 Rosenschein Jun 1996 A
5529076 Schachar Jun 1996 A
5542928 Evans et al. Aug 1996 A
5549628 Cooper et al. Aug 1996 A
5554172 Horner et al. Sep 1996 A
5562608 Sekins et al. Oct 1996 A
5575803 Cooper et al. Nov 1996 A
5584872 LaFontaine et al. Dec 1996 A
5591157 Hennings et al. Jan 1997 A
5591162 Fletcher et al. Jan 1997 A
5616120 Andrew et al. Apr 1997 A
5620440 Heckele et al. Apr 1997 A
5669907 Platt, Jr. et al. Sep 1997 A
5681282 Eggers et al. Oct 1997 A
5683366 Eggers et al. Nov 1997 A
5695507 Auth et al. Dec 1997 A
5697281 Eggers et al. Dec 1997 A
5697536 Eggers et al. Dec 1997 A
5697882 Eggers et al. Dec 1997 A
5697909 Eggers et al. Dec 1997 A
5700262 Acosta et al. Dec 1997 A
5707352 Sekins et al. Jan 1998 A
5735811 Brisken Apr 1998 A
5741247 Rizoiu et al. Apr 1998 A
5741248 Stern et al. Apr 1998 A
5752965 Francis et al. May 1998 A
5755753 Knowlton May 1998 A
5782914 Schankereli Jul 1998 A
5785521 Rizoiu et al. Jul 1998 A
5800482 Pomeranz et al. Sep 1998 A
5810764 Eggers et al. Sep 1998 A
5824703 Clark, Jr. Oct 1998 A
5827268 Laufer Oct 1998 A
5836896 Rosenschein Nov 1998 A
5843019 Eggers et al. Dec 1998 A
5843073 Sinofsky Dec 1998 A
5871469 Eggers et al. Feb 1999 A
5879329 Ginsburg Mar 1999 A
5885243 Capetan et al. Mar 1999 A
5888198 Eggers et al. Mar 1999 A
5891095 Eggers et al. Apr 1999 A
5891134 Goble et al. Apr 1999 A
5913856 Chia et al. Jun 1999 A
5938660 Swartz et al. Aug 1999 A
5944686 Patterson et al. Aug 1999 A
5944715 Goble et al. Aug 1999 A
5957919 Laufer Sep 1999 A
5964752 Stone Oct 1999 A
5968037 Rizoiu Oct 1999 A
5980504 Sharkey et al. Nov 1999 A
5986662 Argiro et al. Nov 1999 A
5989212 Sussman et al. Nov 1999 A
5989238 Ginsburg Nov 1999 A
5989249 Kirwan Nov 1999 A
5989445 Wise et al. Nov 1999 A
5997499 Sussman et al. Dec 1999 A
6024095 Stanley, III Feb 2000 A
6024733 Eggers et al. Feb 2000 A
6027501 Goble et al. Feb 2000 A
6032077 Pomeranz Feb 2000 A
6032674 Eggers et al. Mar 2000 A
6047700 Eggers et al. Apr 2000 A
6053909 Shadduck Apr 2000 A
6056746 Goble et al. May 2000 A
6059011 Giolo May 2000 A
6063079 Hovda et al. May 2000 A
6063081 Mulier et al. May 2000 A
6066134 Eggers et al. May 2000 A
6074358 Andrew et al. Jun 2000 A
6080128 Sussman et al. Jun 2000 A
6080151 Swartz et al. Jun 2000 A
6083255 Laufer et al. Jul 2000 A
6095149 Sharkey et al. Aug 2000 A
6099251 LaFleur Aug 2000 A
6102046 Weinstein et al. Aug 2000 A
6102885 Bass Aug 2000 A
6106516 Bmassengill Aug 2000 A
6110162 Sussman et al. Aug 2000 A
6113722 Hoffman et al. Sep 2000 A
6126682 Sharkey et al. Oct 2000 A
6130671 Argiro Oct 2000 A
6139571 Fuller et al. Oct 2000 A
6149620 Baker et al. Nov 2000 A
6156036 Sussman et al. Dec 2000 A
6159194 Eggers et al. Dec 2000 A
6162232 Shadduck Dec 2000 A
6168594 LaFontaine et al. Jan 2001 B1
6174308 Goble et al. Jan 2001 B1
6179805 Sussman et al. Jan 2001 B1
6190381 Olsen et al. Feb 2001 B1
6194066 Hoffman Feb 2001 B1
6196989 Padget et al. Mar 2001 B1
6200333 Laufer Mar 2001 B1
6206848 Sussman et al. Mar 2001 B1
6210404 Shadduck Apr 2001 B1
6210405 Goble et al. Apr 2001 B1
6219059 Argiro Apr 2001 B1
6224592 Eggers et al. May 2001 B1
6231567 Rizoiu et al. May 2001 B1
6235020 Cheng et al. May 2001 B1
6238391 Olsen et al. May 2001 B1
6254597 Rizoiu et al. Jul 2001 B1
6261286 Goble et al. Jul 2001 B1
6261311 Sharkey et al. Jul 2001 B1
6264650 Hovda et al. Jul 2001 B1
6264651 Underwood et al. Jul 2001 B1
6264654 Swartz et al. Jul 2001 B1
6277112 Underwood et al. Aug 2001 B1
6283910 Bradshaw et al. Sep 2001 B1
6283961 Underwood et al. Sep 2001 B1
6283989 Laufer et al. Sep 2001 B1
6287274 Sussman et al. Sep 2001 B1
6290715 Sharkey et al. Sep 2001 B1
6296636 Cheng et al. Oct 2001 B1
6296638 Davison et al. Oct 2001 B1
6299633 Laufer Oct 2001 B1
6300150 Venkatasubramanian Oct 2001 B1
6312408 Eggers et al. Nov 2001 B1
6312474 Francis et al. Nov 2001 B1
6315755 Sussman Nov 2001 B1
6319222 Andrew et al. Nov 2001 B1
6327505 Medhkour et al. Dec 2001 B1
6331171 Cohen Dec 2001 B1
6355032 Hovda et al. Mar 2002 B1
6375635 Moutafis et al. Apr 2002 B1
6379350 Sharkey et al. Apr 2002 B1
6391025 Weinstein et al. May 2002 B1
6394949 Crowley et al. May 2002 B1
6394996 Lawrence et al. May 2002 B1
6398759 Sussman et al. Jun 2002 B1
6398775 Perkins et al. Jun 2002 B1
6409723 Edwards Jun 2002 B1
6416508 Eggers et al. Jul 2002 B1
6458231 Wapner et al. Oct 2002 B1
6461350 Underwood et al. Oct 2002 B1
6464694 Massengill Oct 2002 B1
6464695 Hovda et al. Oct 2002 B2
6468270 Hovda et al. Oct 2002 B1
6468274 Alleyne et al. Oct 2002 B1
6468313 Claeson et al. Oct 2002 B1
6482201 Olsen et al. Nov 2002 B1
6482202 Goble et al. Nov 2002 B1
6488673 Laufer et al. Dec 2002 B1
6493589 Medhkour et al. Dec 2002 B1
6500173 Underwood et al. Dec 2002 B2
6508816 Shadduck Jan 2003 B2
6517568 Sharkey et al. Feb 2003 B1
6522930 Schaer et al. Feb 2003 B1
6527761 Soltesz et al. Mar 2003 B1
6527766 Bair Mar 2003 B1
6540741 Underwood et al. Apr 2003 B1
6544211 Andrew et al. Apr 2003 B1
6544248 Bass Apr 2003 B1
6547810 Sharkey et al. Apr 2003 B1
6558379 Batchelor et al. May 2003 B1
6575929 Sussman et al. Jun 2003 B2
6575968 Eggers et al. Jun 2003 B1
6579270 Sussman et al. Jun 2003 B2
6582423 Thapliyal et al. Jun 2003 B1
6585639 Kotmel et al. Jul 2003 B1
6588613 Pechenik et al. Jul 2003 B1
6589201 Sussman et al. Jul 2003 B1
6589204 Sussman et al. Jul 2003 B1
6592594 Rimbaugh et al. Jul 2003 B2
6595990 Weinstein et al. Jul 2003 B1
6599311 Biggs et al. Jul 2003 B1
6602248 Sharps et al. Aug 2003 B1
6605087 Swartz et al. Aug 2003 B2
6610043 Ingenito Aug 2003 B1
6620130 Ginsburg Sep 2003 B1
6620155 Underwood et al. Sep 2003 B2
6623444 Babaev Sep 2003 B2
6632193 Davison et al. Oct 2003 B1
6632220 Eggers et al. Oct 2003 B1
6634363 Danek et al. Oct 2003 B1
6648847 Sussman et al. Nov 2003 B2
6652594 Francis et al. Nov 2003 B2
6653525 Ingenito et al. Nov 2003 B2
6659106 Hovda et al. Dec 2003 B1
6669685 Rizoiu et al. Dec 2003 B1
6669694 Shadduck Dec 2003 B2
6676628 Sussman et al. Jan 2004 B2
6676629 Andrew et al. Jan 2004 B2
6679264 Deem et al. Jan 2004 B1
6679879 Shadduck Jan 2004 B2
6682520 Ingenito Jan 2004 B2
6682543 Barbut et al. Jan 2004 B2
6692494 Cooper et al. Feb 2004 B1
6695839 Sharkey et al. Feb 2004 B2
6699212 Kadziauskas et al. Mar 2004 B1
6699244 Carranza et al. Mar 2004 B2
6712811 Underwood et al. Mar 2004 B2
6712812 Roschak et al. Mar 2004 B2
6719738 Mehier Apr 2004 B2
6719754 Underwood et al. Apr 2004 B2
6723064 Babaev Apr 2004 B2
6726684 Woloszko et al. Apr 2004 B1
6726708 Lasheras Apr 2004 B2
6746447 Davison et al. Jun 2004 B2
6755794 Soukup Jun 2004 B2
6758846 Goble et al. Jul 2004 B2
6763836 Tasto et al. Jul 2004 B2
6764487 Mulier et al. Jul 2004 B2
6766202 Underwood et al. Jul 2004 B2
6770070 Balbierz Aug 2004 B1
6770071 Woloszko et al. Aug 2004 B2
6772012 Ricart et al. Aug 2004 B2
6776765 Soukup et al. Aug 2004 B2
6780180 Goble et al. Aug 2004 B1
6805130 Tasto et al. Oct 2004 B2
6813520 Truckai et al. Nov 2004 B2
6832996 Woloszko et al. Dec 2004 B2
6837884 Woloszko Jan 2005 B2
6837888 Ciarrocca et al. Jan 2005 B2
6852108 Barry et al. Feb 2005 B2
6860847 Alferness et al. Mar 2005 B2
6860868 Sussman et al. Mar 2005 B1
6875194 MacKool Apr 2005 B2
6896674 Woloszko et al. May 2005 B1
6896675 Leung et al. May 2005 B2
6901927 Deem et al. Jun 2005 B2
6904909 Andreas et al. Jun 2005 B2
6907881 Suki et al. Jun 2005 B2
6911028 Shadduck Jun 2005 B2
6918903 Bass Jul 2005 B2
6921385 Clements et al. Jul 2005 B2
6929640 Underwood et al. Aug 2005 B1
6949096 Davison et al. Sep 2005 B2
6955675 Jain Oct 2005 B2
6960182 Moutafis et al. Nov 2005 B2
6962584 Stone et al. Nov 2005 B1
6972014 Eum et al. Dec 2005 B2
6978174 Gelfand et al. Dec 2005 B2
6986769 Nelson et al. Jan 2006 B2
6991028 Comeaux et al. Jan 2006 B2
6991631 Woloszko et al. Jan 2006 B2
7022088 Keast et al. Apr 2006 B2
7031504 Argiro et al. Apr 2006 B1
7083612 Littrup et al. Aug 2006 B2
7094249 Broome et al. Aug 2006 B1
7128748 Mooradian et al. Oct 2006 B2
7136064 Zuiderveld Nov 2006 B2
7144402 Kuester, III Dec 2006 B2
7144588 Oray et al. Dec 2006 B2
7162303 Levin et al. Jan 2007 B2
7192400 Campbell et al. Mar 2007 B2
7233820 Gilboa Jun 2007 B2
7235070 Vanney Jun 2007 B2
7311708 McClurken Dec 2007 B2
7335195 Mehier Feb 2008 B2
7347859 Garabedian et al. Mar 2008 B2
7524315 Blott et al. Apr 2009 B2
7549987 Shadduck Jun 2009 B2
7585295 Ben-Nun Sep 2009 B2
7617005 Demarais et al. Nov 2009 B2
7620451 Demarais et al. Nov 2009 B2
7647115 Levin et al. Jan 2010 B2
7653438 Deem et al. Jan 2010 B2
7674259 Shadduck Mar 2010 B2
7717948 Demarais et al. May 2010 B2
7756583 Demarais et al. Jul 2010 B2
7815616 Boehringer et al. Oct 2010 B2
7815646 Hart Oct 2010 B2
7853333 Demarais Dec 2010 B2
7873417 Demarais et al. Jan 2011 B2
7892229 Shadduck et al. Feb 2011 B2
7937143 Demarais et al. May 2011 B2
7993323 Barry et al. Aug 2011 B2
8016823 Shadduck Sep 2011 B2
8131371 Demarals et al. Mar 2012 B2
8131372 Levin et al. Mar 2012 B2
8145316 Deem et al. Mar 2012 B2
8145317 Demarais et al. Mar 2012 B2
8150518 Levin et al. Apr 2012 B2
8150519 Demarais et al. Apr 2012 B2
8150520 Demarais et al. Apr 2012 B2
8175711 Demarais et al. May 2012 B2
8187269 Shadduck et al. May 2012 B2
8313485 Shadduck Nov 2012 B2
8444636 Shadduck et al. May 2013 B2
8574226 Shadduck Nov 2013 B2
8579888 Hoey et al. Nov 2013 B2
8579892 Hoey et al. Nov 2013 B2
8579893 Hoey Nov 2013 B2
20010020167 Woloszko et al. Sep 2001 A1
20010029370 Hodva et al. Oct 2001 A1
20010037106 Shadduck Nov 2001 A1
20020049438 Sharkey et al. Apr 2002 A1
20020077516 Flanigan Jun 2002 A1
20020078956 Sharpe et al. Jun 2002 A1
20020082667 Shadduck Jun 2002 A1
20020095152 Ciarrocca et al. Jul 2002 A1
20020111386 Sekins et al. Aug 2002 A1
20020128638 Chauvet et al. Sep 2002 A1
20020133147 Marchitto et al. Sep 2002 A1
20020161326 Sussman et al. Oct 2002 A1
20020177846 Mulier et al. Nov 2002 A1
20020193789 Underwood et al. Dec 2002 A1
20030028189 Woloszko et al. Feb 2003 A1
20030040742 Underwood et al. Feb 2003 A1
20030097126 Woloszko et al. May 2003 A1
20030099279 Venkatasubramanian et al. May 2003 A1
20030109869 Shadduck Jun 2003 A1
20030130655 Woloszko et al. Jul 2003 A1
20030130738 Hovda et al. Jul 2003 A1
20030144654 Hilal Jul 2003 A1
20030158545 Hovda et al. Aug 2003 A1
20030163178 Davison et al. Aug 2003 A1
20030181922 Alferness Sep 2003 A1
20030212394 Pearson et al. Nov 2003 A1
20030212395 Woloszko et al. Nov 2003 A1
20030225364 Kraft et al. Dec 2003 A1
20040024398 Hovda et al. Feb 2004 A1
20040024399 Sharps et al. Feb 2004 A1
20040031494 Danek et al. Feb 2004 A1
20040038868 Ingenito Feb 2004 A1
20040047855 Ingenito Mar 2004 A1
20040049180 Sharps et al. Mar 2004 A1
20040054366 Davison et al. Mar 2004 A1
20040055606 Hendricksen et al. Mar 2004 A1
20040068256 Rizoiu et al. Apr 2004 A1
20040068306 Shadduck Apr 2004 A1
20040087937 Eggers et al. May 2004 A1
20040116922 Hovda et al. Jun 2004 A1
20040193150 Sharkey et al. Sep 2004 A1
20040199226 Shadduck Oct 2004 A1
20040230190 Dahla et al. Nov 2004 A1
20040254532 Mehier Dec 2004 A1
20050004634 Ricart et al. Jan 2005 A1
20050010205 Hovda et al. Jan 2005 A1
20050070894 McClurken Mar 2005 A1
20050119650 Sanders et al. Jun 2005 A1
20050166925 Wilson et al. Aug 2005 A1
20050171582 Matlock Aug 2005 A1
20050187543 Underwood et al. Aug 2005 A1
20050215991 Altman et al. Sep 2005 A1
20050222485 Shaw et al. Oct 2005 A1
20050228423 Khashayar et al. Oct 2005 A1
20050228424 Khashayar et al. Oct 2005 A1
20050240171 Forrest Oct 2005 A1
20050267467 Paul et al. Dec 2005 A1
20050283143 Rizoiu Dec 2005 A1
20060004400 McGurk et al. Jan 2006 A1
20060047291 Barry Mar 2006 A1
20060085054 Zikorus et al. Apr 2006 A1
20060100619 McClurken et al. May 2006 A1
20060130830 Barry Jun 2006 A1
20060135955 Shadduck Jun 2006 A1
20060142783 Lewis et al. Jun 2006 A1
20060161233 Barry et al. Jul 2006 A1
20060200076 Gonzalez et al. Sep 2006 A1
20060206150 Demarais et al. Sep 2006 A1
20060224154 Shadduck et al. Oct 2006 A1
20060271111 Demarais et al. Nov 2006 A1
20070032785 Diederich et al. Feb 2007 A1
20070036417 Argiro et al. Feb 2007 A1
20070091087 Zuiderveld Apr 2007 A1
20070129720 Demarais et al. Jun 2007 A1
20070129760 Demarais et al. Jun 2007 A1
20070129761 Demarais et al. Jun 2007 A1
20070135875 Demarais et al. Jun 2007 A1
20070265687 Deem et al. Nov 2007 A1
20080033493 Deckman et al. Feb 2008 A1
20080097429 McClurken Apr 2008 A1
20080103566 Mehier May 2008 A1
20080110457 Barry et al. May 2008 A1
20080114297 Barry et al. May 2008 A1
20080125747 Prokop May 2008 A1
20080132826 Shadduck et al. Jun 2008 A1
20080213331 Gelfand et al. Sep 2008 A1
20080255642 Zarins et al. Oct 2008 A1
20090036948 Levin et al. Feb 2009 A1
20090054871 Sharkey et al. Feb 2009 A1
20090062873 Wu et al. Mar 2009 A1
20090076409 Wu et al. Mar 2009 A1
20090105702 Shadduck Apr 2009 A1
20090105703 Shadduck Apr 2009 A1
20090125009 Zikorus et al. May 2009 A1
20090149846 Hoey et al. Jun 2009 A1
20090216220 Hoey et al. Aug 2009 A1
20090306640 Glaze et al. Dec 2009 A1
20090312753 Shadduck Dec 2009 A1
20100076416 Hoey et al. Mar 2010 A1
20100094270 Sharma Apr 2010 A1
20100114083 Sharma May 2010 A1
20100137860 Demarais et al. Jun 2010 A1
20100137952 Demarais et al. Jun 2010 A1
20100160905 Shadduck Jun 2010 A1
20100168731 Wu et al. Jul 2010 A1
20100168739 Wu et al. Jul 2010 A1
20100174282 Demarais et al. Jul 2010 A1
20100179528 Shadduck et al. Jul 2010 A1
20100185189 Hoey Jul 2010 A1
20100191112 Demarais et al. Jul 2010 A1
20100204688 Hoey et al. Aug 2010 A1
20100222851 Deem et al. Sep 2010 A1
20100222854 Demarais et al. Sep 2010 A1
20100249773 Clark et al. Sep 2010 A1
20100262133 Hoey et al. Oct 2010 A1
20100268307 Demarais et al. Oct 2010 A1
20110060324 Wu et al. Mar 2011 A1
20110077628 Hoey et al. Mar 2011 A1
20110112400 Emery et al. May 2011 A1
20110160648 Hoey Jun 2011 A1
20110264090 Shadduck et al. Oct 2011 A1
20120065632 Shadduck Mar 2012 A1
Foreign Referenced Citations (10)
Number Date Country
WO 0011927 Mar 2000 WO
WO 0029055 May 2000 WO
WO 03070302 May 2000 WO
WO 02069821 Sep 2002 WO
WO 03086498 Oct 2003 WO
WO 2005025635 Mar 2005 WO
WO 2005102175 Nov 2005 WO
WO 2006003665 Jan 2006 WO
WO 2006055695 May 2006 WO
WO 2009009398 Jan 2009 WO
Non-Patent Literature Citations (16)
Entry
Coda, et al., “Effects of pulmonary reventilation on gas exchange after cryolytic disobstruction of endobronchial tumors,” Minerva Medical, vol. 72, pp. 1627-1631, Jun. 1981 (with English translation).
Fishman et al., “A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema,” N Engl J Med, vol. 348, No. 21, pp. 2059-2073, May 22, 2003.
Homasson, et al., “Bronchoscopic cryotherapy for airway strictures caused by tumors,” Chest, vol. 90, No. 2, pp, 159-164, Aug. 1986.
Li, K., “Efficient optimal net surface detection for image segmentation—from theory to practice,” M.Sc. Thesis, The University of Iowa, 2003.
Marasso, et al., “Cryosurgery in bronchoscopic treatment of tracheobronchial stenosis,” Chest, vol. 103, No. 2, pp. 472-474, Feb. 1993.
Marasso, et al., “Radiofrequency resection of bronchial tumours in combination with cryotherapy: evaluation of a new technique,” Thorax, vol. 53, pp. 106-109, 1998.
Mathur et al., “Fiberoptic bronchoscopic cryotherapy in the management of tracheobronchial obstruction,” Chest, vol. 110, No. 3, pp. 718-723, Sep. 1996.
Morice et al. “Endobrinchial argon plasma coagulation for treatment of hemotysis and neoplastic airway obstruction,” Chest, vol. 119, No. 3, pp. 781-787, Mar. 2001.
Moulding et al., “Preliminary studies for achieving transcervical oviduct occlusion by hot water or low-pressure steam,” Advancesin Planned Parenthood, vol. 12, No. 2, pp. 79-85, 1977.
Quin, J., “Use of neodymium yttrium aluminum garnet laser in long-term palliation of airway obstruction,” Connecticut Medicine, vol. 59, No. 7, pp. 407-412, Jul. 1995.
Sutedja, et al., “Bronchoscopic treatment of lung tumors,” Elsevier, Lung Cancer, 11, pp. 1-17, 1994.
Tschirren et al.; “Intrathoracic airway trees: segmentation and airway morphology analysis from low-dose CT scans;” IEEE Trans. Med. Imaging, vol. 24, No. 12; pp. 1529-1539, Dec. 2005.
Tschirren, J., “Segmentation, anatomical labeling, branchpoint matching, and quantitative analysis of human airway trees in volumetric CT images,” Ph.D. Thesis, The University of Iowa, 231 pages, Aug. 2003.
Tschirren, J., “Segmentation, anatomical labeling, branchpoint matching, and quantitative analysis of human airway trees in volumetric CT images,” Slides from Ph.D. defense, University of Iowa, 130 pages, Aug. 2003.
Unger, M. et al. “Monolithic Microfabricated Valves and Pumps by Multilayer Soft Lithography,” Science, vol. 288, pp. 113-116, Apr. 7, 2000, accessed at http://web.mit.edu/thorsen/www/113.pdf.
Xia, Y. et al. “Soft Lithography,” Annu. Rev. Mater. Sci., vol. 28, pp. 153-184, 1998, accessed at http://www.bwfoundry.com/xia.pdf.
Related Publications (1)
Number Date Country
20110118717 A1 May 2011 US
Provisional Applications (1)
Number Date Country
61259097 Nov 2009 US